• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗中的细菌:新一代武器。

Bacteria in cancer therapy: A new generation of weapons.

机构信息

Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, P.R. China.

Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, P.R. China.

出版信息

Cancer Med. 2022 Dec;11(23):4457-4468. doi: 10.1002/cam4.4799. Epub 2022 May 6.

DOI:10.1002/cam4.4799
PMID:35522104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9741989/
Abstract

Tumors are presently a major threat to human life and health. Malignant tumors are conventionally treated through radiotherapy and chemotherapy. However, traditional therapies yield unsatisfactory results due to high toxicity to the normal cells, inability to treat deep tumor tissues, and the possibility of inducing drug resistance in the tumor cells. This has caused immunotherapy to emerge as an effective and alternate treatment strategy. To overcome the limitations of the conventional treatments as well as to avert the risk of various drug resistance and cytotoxicity, bacterial anti-tumor immunotherapy has raised the interest of researchers. This therapeutic strategy employs bacteria to specifically target and colonize the tumor tissues with preferential accumulation and proliferation. Such bacterial accumulation initiates a series of anti-tumor immune responses, effectively eliminating the tumor cells. This immunotherapy can use the bacteria alone or concomitantly with the other methods. For example, the bacteria can deliver the anti-cancer effect mediators by regulating the expression of the bacterial genes or by synthesizing the bioengineered bacterial complexes. This review will discuss the mechanism of utilizing bacteria in treating tumors, especially in terms of immune mechanisms. This could help in better integrating the bacterial method with other treatment options, thereby, providing a more effective, reliable, and unique treatment therapy for tumors.

摘要

肿瘤目前是对人类生命和健康的主要威胁。恶性肿瘤通常通过放疗和化疗来治疗。然而,由于对正常细胞的毒性高、无法治疗深部肿瘤组织以及肿瘤细胞可能产生耐药性等原因,传统疗法的效果并不理想。这使得免疫疗法成为一种有效的替代治疗策略。为了克服传统治疗方法的局限性,并避免各种耐药性和细胞毒性的风险,细菌抗肿瘤免疫疗法引起了研究人员的兴趣。这种治疗策略利用细菌特异性地靶向和定植肿瘤组织,具有优先的积累和增殖。这种细菌的积累会引发一系列抗肿瘤免疫反应,有效地消除肿瘤细胞。这种免疫疗法可以单独使用细菌,也可以与其他方法同时使用。例如,细菌可以通过调节细菌基因的表达或合成生物工程细菌复合物来传递抗癌效应介质。本文将讨论利用细菌治疗肿瘤的机制,特别是免疫机制。这有助于更好地将细菌方法与其他治疗方案结合起来,从而为肿瘤提供更有效、可靠和独特的治疗方法。

相似文献

1
Bacteria in cancer therapy: A new generation of weapons.癌症治疗中的细菌:新一代武器。
Cancer Med. 2022 Dec;11(23):4457-4468. doi: 10.1002/cam4.4799. Epub 2022 May 6.
2
Bacteria-cancer interactions: bacteria-based cancer therapy.细菌-癌症相互作用:基于细菌的癌症疗法。
Exp Mol Med. 2019 Dec 11;51(12):1-15. doi: 10.1038/s12276-019-0297-0.
3
Dual Role of Bacteria in Carcinoma: Stimulation and Inhibition.细菌在癌症中的双重作用:刺激与抑制
Int J Microbiol. 2020 Aug 24;2020:4639761. doi: 10.1155/2020/4639761. eCollection 2020.
4
Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?放疗与免疫治疗联合治疗肺癌:正常组织毒性改变是否会带来限制?
Int J Mol Sci. 2018 Dec 21;20(1):24. doi: 10.3390/ijms20010024.
5
Bacteria and cancer: Different sides of the same coin.细菌与癌症:同一枚硬币的两面。
Life Sci. 2020 Apr 1;246:117398. doi: 10.1016/j.lfs.2020.117398. Epub 2020 Feb 4.
6
Current advances in microbial-based cancer therapies.基于微生物的癌症治疗的最新进展。
Med Oncol. 2023 Jun 18;40(7):207. doi: 10.1007/s12032-023-02074-x.
7
Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?细菌免疫疗法:它是我们对抗癌症的武器库中的一种武器吗?
Front Immunol. 2023 Nov 27;14:1277677. doi: 10.3389/fimmu.2023.1277677. eCollection 2023.
8
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities.治疗性细菌对抗癌症:当前进展、挑战和机遇。
Cancer Med. 2019 Jun;8(6):3167-3181. doi: 10.1002/cam4.2148. Epub 2019 Apr 5.
9
Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy.基于细菌的癌症治疗(BBCT):癌症免疫治疗的最新进展、当前挑战及未来前景
Vaccines (Basel). 2021 Dec 18;9(12):1497. doi: 10.3390/vaccines9121497.
10
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.免疫化疗:剂量和方案依赖性以及与免疫疗法的联合应用。
Cancer Lett. 2018 Apr 10;419:210-221. doi: 10.1016/j.canlet.2018.01.050.

引用本文的文献

1
The human microbiome: redefining cancer pathogenesis and therapy.人类微生物组:重新定义癌症发病机制与治疗
Cancer Cell Int. 2025 Apr 28;25(1):165. doi: 10.1186/s12935-025-03787-x.
2
Thermal-responsive ultrasound activatable production of therapeutics for real-time imaging and targeted tumor therapy.用于实时成像和靶向肿瘤治疗的热响应性超声可激活治疗剂的生产。
Theranostics. 2025 Mar 18;15(9):4212-4228. doi: 10.7150/thno.101714. eCollection 2025.
3
Exploring the role of oral bacteria in oral cancer: a narrative review.探索口腔细菌在口腔癌中的作用:一篇叙述性综述。

本文引用的文献

1
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.纳武利尤单抗联合伊匹单抗联合或不联合活菌制剂治疗转移性肾细胞癌的随机 1 期试验。
Nat Med. 2022 Apr;28(4):704-712. doi: 10.1038/s41591-022-01694-6. Epub 2022 Feb 28.
2
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1.抗 PD-1 治疗的黑色素瘤患者临床应答和免疫相关不良事件的肠道微生物组特征
Nat Med. 2022 Mar;28(3):545-556. doi: 10.1038/s41591-022-01698-2. Epub 2022 Feb 28.
3
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.
Discov Oncol. 2025 Feb 26;16(1):242. doi: 10.1007/s12672-025-01998-2.
4
Anti-tumor Effects of Recombinant Clostridium α-Toxin on Breast Cancer: An and Study.重组梭菌α毒素对乳腺癌的抗肿瘤作用:一项[未提及具体内容]研究
Int J Mol Cell Med. 2024;13(4):404-416. doi: 10.22088/IJMCM.BUMS.13.4.404.
5
Photosynthetic Bacteria: Light-Responsive Biomaterials for Anti-Tumor Photodynamic Therapy.光合细菌:用于抗肿瘤光动力疗法的光响应生物材料。
Int J Nanomedicine. 2025 Jan 10;20:465-482. doi: 10.2147/IJN.S500314. eCollection 2025.
6
Beyond Tumor Borders: Intratumoral Microbiome Effects on Tumor Behavior and Therapeutic Responses.超越肿瘤边界:瘤内微生物群对肿瘤行为和治疗反应的影响
Immune Netw. 2024 Dec 9;24(6):e40. doi: 10.4110/in.2024.24.e40. eCollection 2024 Dec.
7
Intratumoral Injection of Engineered Induces Antitumor Immunity and Inhibits Tumor Growth.瘤内注射工程化制剂可诱导抗肿瘤免疫并抑制肿瘤生长。
Biomater Res. 2024 Jan 7;29:0130. doi: 10.34133/bmr.0130. eCollection 2025.
8
Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy.利用细菌制剂调节肿瘤微环境并增强癌症免疫疗法。
Cancers (Basel). 2024 Nov 13;16(22):3810. doi: 10.3390/cancers16223810.
9
Microbial Therapeutics in Oncology: A Comprehensive Review of Bacterial Role in Cancer Treatment.肿瘤学中的微生物疗法:细菌在癌症治疗中作用的全面综述
Cureus. 2024 Oct 6;16(10):e70920. doi: 10.7759/cureus.70920. eCollection 2024 Oct.
10
Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials.利用细菌代谢物增强癌症化疗:揭示独特的治疗潜力。
Arch Microbiol. 2024 Oct 29;206(11):449. doi: 10.1007/s00203-024-04179-x.
跨队列肠道微生物组与晚期黑色素瘤免疫检查点抑制剂反应的关联。
Nat Med. 2022 Mar;28(3):535-544. doi: 10.1038/s41591-022-01695-5. Epub 2022 Feb 28.
4
IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella.IFN-γ 依赖性 NK 细胞的激活对于工程化沙门氏菌抑制转移是必不可少的。
Nat Commun. 2021 May 5;12(1):2537. doi: 10.1038/s41467-021-22755-3.
5
Gut Microbiota in Cancer Immune Response and Immunotherapy.肠道微生物群在癌症免疫反应和免疫治疗中的作用。
Trends Cancer. 2021 Jul;7(7):647-660. doi: 10.1016/j.trecan.2021.01.010. Epub 2021 Mar 2.
6
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.粪便微生物移植克服了黑色素瘤患者对抗 PD-1 治疗的耐药性。
Science. 2021 Feb 5;371(6529):595-602. doi: 10.1126/science.abf3363.
7
-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy.基于靶向吲哚胺2,3-双加氧酶的疗法可重塑免疫格局以提高检查点阻断疗效。
Biomedicines. 2020 Dec 16;8(12):617. doi: 10.3390/biomedicines8120617.
8
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.粪便微生物移植可促进免疫治疗耐药性黑色素瘤患者的应答。
Science. 2021 Feb 5;371(6529):602-609. doi: 10.1126/science.abb5920. Epub 2020 Dec 10.
9
Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome.桩蛋白介导ATP诱导的P2X7受体和NLRP3炎性小体激活。
BMC Biol. 2020 Nov 26;18(1):182. doi: 10.1186/s12915-020-00918-w.
10
Anti-tumor effect of a recombinant Bifidobacterium strain secreting a claudin-targeting molecule in a mouse breast cancer model.靶向紧密连接分子的重组双歧杆菌在小鼠乳腺癌模型中的抗肿瘤作用。
Eur J Pharmacol. 2020 Nov 15;887:173596. doi: 10.1016/j.ejphar.2020.173596. Epub 2020 Sep 28.